Market Closed -
Other stock markets
|
After market 07:00:00 pm | |||
28.53 USD | -0.38% | 28.52 | -0.05% |
May. 20 | Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft... | |
May. 20 | DA Davidson Raises Price Target on Pfizer to $35 From $30, Maintains Buy/Add Rating | MT |
Financials (USD)
Sales 2024 * | 60.41B | Sales 2025 * | 62.7B | Capitalization | 162B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B | Net income 2025 * | 11.29B | EV / Sales 2024 * | 3.65 x |
Net Debt 2024 * | 58.11B | Net Debt 2025 * | 49.97B | EV / Sales 2025 * | 3.39 x |
P/E ratio 2024 * |
19.8
x | P/E ratio 2025 * |
13.9
x | Employees | 88,000 |
Yield 2024 * |
5.92% | Yield 2025 * |
6.04% | Free-Float | 59.05% |
Latest transcript on Pfizer, Inc.
1 day | +0.02% | ||
1 week | +0.32% | ||
Current month | +11.36% | ||
1 month | +9.73% | ||
3 months | +3.41% | ||
6 months | -4.84% | ||
Current year | -0.90% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 254 M€ | +10.44% | - | |
9.37% | 17 M€ | +8.10% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 28.53 | -0.38% | 21,636,886 |
24-05-17 | 28.64 | -0.97% | 26,106,406 |
24-05-16 | 28.92 | +0.35% | 40,077,782 |
24-05-15 | 28.82 | +1.55% | 38,376,257 |
24-05-14 | 28.38 | -0.21% | 23,530,856 |
Delayed Quote Nyse, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.90% | 162B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- PFE Stock